Sonire Therapeutics Completes Enrollment in SUNRISE-I Randomized Controlled Trial of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer

Pivotal Japan-based study evaluates efficacy and safety of non-invasive HIFU system in pancreatic cancer, complementing ongoing U.S. clinical program PALO ALTO, Calif., June 1, 2026 /PRNewswire/ -- Sonire Therapeutics, a U.S.-based clinical-stage medical device company, today announced...